It was a triumph of medical science over tragedy.
The case involved a 29-year-old woman suffering an ectopic pregnancy in which the embryo becomes embedded outside the uterus, usually in one of the fallopian tubes.
Often, in such instances, in order to save the life of the mother, termination of the pregnancy is the only remedy.
But Malcolm Pearce, an obstetrician at St Georges Hospital Medical School, London, had performed a minor miracle.
He had successfully extracted the embryo, then reimplanted it into the patients womb.
And she had gone on to have a healthy baby. It was a feat numerous other surgeons had tried but failed to achieve.
The astonishing story was reported in the British Journal Of Obstetrics and made headlines around the world.
No doubt it also offered hope to the thousands of women who suffer such traumatic events each year.
Malcolm Pearce (pictured) was sacked, found guilty of serious professional misconduct and struck off the medical register for falsifying a medical study
Or rather, it would have if it hadnt turned out to have been a lie.
Shortly after publication, in 1995, the journal was approached by a whistleblower at St Georges claiming that Pearces story was a fabrication.
Investigations subsequently revealed the surgeon had tampered with computer records and amalgamated patients notes those of a woman who was dead and another who had miscarried to create a fictitious patient.
Pearce, who it transpired had falsified another study into drugs to prevent miscarriage, was sacked, found guilty of serious professional misconduct and struck off the medical register.
We speak to experts exposing the scandal of fake medical research
It is a disturbing tale. But not a one-off. According to bombshell allegations from a group of highly respected experts, the medical world is rife with research fraud.
Their investigations suggest up to one in five of the estimated two million medical studies published each year could contain invented or plagiarised results, details of patients who never existed and trials that didnt actually take place.
The problem is well known about in science circles, says Richard Smith, former editor-in-chief of the British Medical Journal (BMJ) yet there is a reluctance within the establishment to accept the scale of the problem.
In a recent article, he suggested the only way to combat research fraud is for journal editors to view all studies submitted as potential fakes until they can be proven otherwise.
Speaking on The Mail on Sundays Medical Minefield podcast, Smith who was involved in the investigations that exposed Malcolm Pearce said: Its shocking, but common.
Many of these fraudulent studies are simply invented. There were no patients. The trial never happened.
Research coming out of countries where doctors are commonly rewarded with pay rises for publishing their work such as Egypt, Iran, India and China is more likely to be faked, investigations show.
In China, doctors can only get promoted if they score enough points, by getting published, says John Carlisle, an NHS anaesthetist who spends his spare time hunting for fraudulent medical studies.
Korean pioneer Woo Suk Hwang (pictured) became a national hero when he and his research team reportedly cloned a human embryo and extracted stem cells from it a technique that could potentially cure a wide range of diseases. The claims turned out to be bogus.
Meanwhile, Professor Lisa Bero, an expert in study fraud at Cochrane, one of the worlds foremost research organisations, warns of paper mills shadowy companies that operate online, churning out sham studies much like the essay mills that profit by selling work to students.
Academics investigating these paper mills recently flagged more than 1,000 potential research fraud cases linked to them.
Paper mills can generate hundreds of fraudulent studies, far more than the odd bad egg researcher, and saturate certain topics, such as cardiology. I expect well only see more of it in the future, adds Prof Bero.
Despite being vocal about their concerns, Smith and others argue little has been done within the mainstream medical world over the past few decades to stem the tide of tainted data, which means it will likely have been used to underpin NHS medical guidance, potentially putting lives at risk.
I have no doubt that this is a major threat to global public health, warns Ian Roberts, Professor of Epidemiology at the London School of Hygiene & Tropical Medicine, who claims the regulatory systems are not fit for purpose.
In the mid-1990s, South African oncologist Dr Werner Bezwoda claimed to have effectively cured women with late-stage breast cancer by giving them bone-marrow transplants.
His findings, published in major medical journals, were later revealed to have been invented but not before thousands of patients had died after undergoing the ineffective treatment.
Eric Poehlman, a Canadian researcher, was the first and one of the only scientists to be jailed for research fraud after ten of his publicly funded studies looking at weight gain in the menopause, ageing and hormone-replacement therapy were found to be fabricated.
Then theres Korean pioneer Woo Suk Hwang, who became a national hero when he and his research team reportedly cloned a human embryo and extracted stem cells from it a technique that could potentially cure a wide range of diseases. The claims turned out to be bogus.
The Covid pandemic, and the global rush to find treatments, has been rife with research fraud, says Prof Bero.
An investigation found that more than a third of the 26 studies into anti-parasitic medication ivermectin, which many hoped could ease Covid symptoms, have signs of potential fraud.
Studies last year looking at whether the antimalarial hydroxychloroquine could reduce Covid severity it was touted as a wonder drug by President Trump were also revealed to have grave flaws.
In 2010, Prof Roberts was involved in a review that flagged up false data in 90 published studies on drugs given to regulate blood pressure during surgery, all authored by the same German anaesthesiologist, Joachim Boldt (pictured)
One, which led to French health chiefs recommending the medication, was found to contain disputed data.
The expert behind it, Marseilles-based microbiologist Didier Raoult, initially threatened legal action against one of the scientists who flagged up anomalies in dozens of his studies.
But Raoult is now due to appear before an ethics committee, accused of spreading false information about the benefits of the medication.
Raoults lawyer has reportedly said his client would be cleared.
Two other major studies that concluded the drug didnt have an effect on Covid were also exposed as potential fakes.
These concluded that hydroxychloroquine was linked to increased deaths and heart problems and were published in world-renowned journals The Lancet and The New England Journal Of Medicine.
They led to the World Health Organisation and several countries halting trials into the drug.
But within days, glaring errors were discovered. Eagle-eyed readers noticed that death rates failed to match official records, and hospitals mentioned in the study later denied ever having provided patient data.
Surgisphere, the company which provided the figures, headed up by US vascular surgeon Dr Sapan Desai, failed to produce detailed patient records when requested.
The papers were retracted. The New England Journal Of Medicine published a statement by the studys authors in which they claimed they were unable to validate the data sources underlying the article, as they were not granted access to the raw data and apologised for difficulties caused.
Commentators have questioned how the respected doctors and editors who reviewed the study before publication failed to spot the problems.
However The Lancets editor Richard Horton called the paper retracted by his journal a fabrication and a monumental fraud.
Anaesthetists became suspicious about studies carried out by Japanese researcher Yoshitaka Fujii (pictured) into a drug given to ease nausea and vomiting after surgery.Further investigation concluded that more than 100 trials he had claimed to have carried out were totally fabricated
He added: If you have an author who deliberately tries to mislead, its surprisingly easy for them to do so.
While these are eye-opening examples, far more common, says Carlisle, are low-level fakes studies that simply confirm what other studies say, so arouse little suspicion.
He adds: Youd think people would manufacture startling results, but in my experience most studies are fairly boring just interesting enough to get published, so they can go on the CV.
For a drug to be licensed for use, manufacturers are legally required to carry out clinical trials to prove it is safe and works.
Once approved, doctors and other researchers are then able to easily use the medicine on patients in their own trials, in order to show how best to use it.
This means there can be hundreds, or even thousands of studies published on certain treatments, all producing differing results and this creates the perfect camouflage for fabricated studies.
In order to produce a more definitive picture, rather than rely on the results of one or two trials, experts carry out systematic reviews, rounding up and assessing numerous studies and looking at the totality of evidence.
If there was the odd fake study, by simple law of averages, a review might effectively neutralise the impact. However, given the sheer scale of the problem of research fraud, fake studies may actually skew the results of reviews, too.
Prof Ian Roberts first became aware of research fraud in the late 1990s while he was carrying out one such systematic review on trials of a drug called mannitol, which was given to reduce brain swelling after head injury.
In the mid-1990s, South African oncologist Dr Werner Bezwoda (pictured) claimed to have effectively cured women with late-stage breast cancer by giving them bone-marrow transplants his findings had been invented
He had concluded the treatment was effective when a colleague suggested that some of the trials had been fabricated.
Prof Roberts says: Three of the mannitol papers had come from Brazil, which was where this guy was from.
He said it was well known, in the medical world there, that many of these trials hadnt actually taken place.
He began to investigate, and discovered, to his horror, that his colleague was right. When he contacted the authors and institutes named on the papers, they either claimed to have no knowledge of the trial mentioned or couldnt provide any further evidence that they took place.
Theyd been fabricated. I could find no other explanation, he says.
When Prof Roberts then removed these problematic studies from his review of Mannitol, the conclusion changed it was not an effective treatment for head injuries.
He says: These fraudulent studies could have meant patients were not given the best treatment, and lives were put at risk.
I flagged it up to the research group I was working for, put it down to bad luck and carried on.
But then it happened again. In 2010, Prof Roberts was involved in a review that flagged up false data in 90 published studies on drugs given to regulate blood pressure during surgery, all authored by the same German anaesthesiologist, Joachim Boldt.
These trials had been published over many years in leading journals, but it turned out they had never happened, says Prof Roberts.
Again, when they were excluded from the review, it showed the treatment was not effective. British surgical guidelines had to be changed.
It made me realise, if someone can get away with fabricating 90 studies, the system isnt working.
Before a study is published in a medical journal, it goes through a process of peer review.
This means other researchers who are not known to the author scrutinise it to look for potential errors.
Surgisphere, a company which provided figures for a potential Covid drug study, headed up by US vascular surgeon Dr Sapan Desai (pictured), failed to produce detailed patient records when requested
However, it is a system entirely based on trust, that the study actually took place, explains former BMJ editor Richard Smith.
For this reason he calls it a flawed process, adding If the author of a paper says there was 200 patients, we assume there were 200.
We dont say, show us their signatures. Just because something had passed through peer review, doesnt mean it isnt fraudulent.
Its difficult to know for certain how widespread the problem of research fakery is.
Roughly four in every 10,000 published end up being retracted withdrawn by the journal in question according to an analysis by Science magazine.
This can be due to honest errors, but in two-thirds of cases there is a suspicion of fraud. The work of NHS anaesthetist John Carlisle may point to further answers.
He first became aware of bogus studies 20 years ago, after he and other anaesthetists became suspicious about studies carried out by Japanese researcher Yoshitaka Fujii into a drug given to ease nausea and vomiting after surgery.
The side-effect rates between the trails were strikingly similar, and identical in some cases, he says. Youd expect some variation.
Further investigation concluded that more than 100 trials he had claimed to have carried out were totally fabricated.
Fujii lost his university job, and by 2010 no fewer than 183 of his papers had been retracted, or withdrawn by the journals that published them.
Despite this, Fujii maintains he did nothing wrong.
Carlisle refined his methods and has carried out two major investigations into research fraud.
By looking for too-good-to-be-true patterns in the data, he found that one study in five published by one journal, Anaesthesia, was potentially fraudulent.
Authors from five countries submitted the majority of trials 48 per cent of Chinese trials, 62 per cent of Indian trials and 90 per cent of Egyptian trials were suspected fakes. A third of South Korean and a fifth of Japanese trials were also possibly bogus.
A similar analysis of more than 5,000 studies published in major journals, including The New England Journal Of Medicine and the Journal Of The American Medical Association, confirmed his early finding, suggesting that 15 per cent could be fraudulent.
Anaesthesia, and the New England Journal, now use Carliles methods to screen all studies submitted for publication, in order to weed out any fakes.
It all begs the questions: why would scientists lie particularly when there are such severe consequences, both in terms of damaging public health, and, should they be caught, on their own careers?
Eric Poehlman (pictured), a Canadian researcher, was the first and one of the only scientists to be jailed for research fraud after ten of his publicly funded studies looking at weight gain in the menopause, ageing and hormone-replacement therapy were found to be fabricated
People lie because its easier than doing a study for real, suggests Carlisle.
Richard Smith agrees: You cant get on in the academic world if you dont publish, and doing studies properly can be a long and difficult process.
You need funding, skills, and a team. In some ways, its easier to simply invent it. And the terrible thing is that its quite easy to get away with it.
Prof Ian Roberts claims he has warned British health watchdog the National Institute for Health and Care Excellence (NICE), the Chief Medical Officers and others about the scale of the problem, but has been all but ignored.
He says: We have written to them but they are not interested. I can understand why no one wants to take it seriously this is a difficult problem to solve and will require huge changes in the way things are done.
When The Mail on Sunday contacted the office of the Chief Medical Officers, it claimed to have no record of Prof Robertss letters despite the fact that we have seen the letter of acknowledgment from Englands Chief Medical Officer, Professor Chris Whitty.
A Government spokesperson said: Clinical Trials are required by law to be conducted to Good Clinical Practice.
This is a set of internationally recognised ethical and scientific quality requirements that must be followed when designing, conducting, recording and reporting clinical trials that involve people.
Read more from the original source:
Exposed: The Plague Of Fake Medical Trials Putting Lives In Danger - Todayuknews - Todayuknews
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
- Is Phenq Right For You? Review The Facts Before Making a ... - Vashon-Maury Island Beachcomber - November 27th, 2023
- Cavityn Reviews - Does It Work? Cheap Scam or Effective ... - The Daily World - November 25th, 2023
- Trend Hunting With Beautystreams At Cosmoprof Asia 2023 - BeautyMatter - November 25th, 2023
- FDA Considers First CRISPR Gene Editing Treatment That May ... - Slashdot - November 25th, 2023
- How Do Plants Determine Where the Light Is Coming From? - Lab Manager Magazine - November 25th, 2023
- Deaths From Coal Pollution Have Dropped, But Emissions May be ... - Slashdot - November 25th, 2023
- Stem cell-based therapies for stroke in newborns - Cochrane - November 23rd, 2023
- Dr Leslie on Outpatient CAR T-Cell Therapy Programs for ... - OncLive - November 23rd, 2023
- Human Milk-Based Therapy May Be Beneficial in Blood Cancers - Curetoday.com - November 23rd, 2023
- Oncological Horizons: The Synergy of Medical and Surgical ... - Cureus - November 23rd, 2023
- Human and environmental safety of carbon nanotubes across their ... - Nature.com - November 23rd, 2023
- Immix Biopharma to Host KOL Event to Discuss its BCMA-Targeted ... - BioSpace - November 23rd, 2023
- #HearTheMarsdenKids call on NHS London to reconsider cancer ... - Metro.co.uk - November 23rd, 2023
- Diagnosis and Management of Cardiovascular Risk in Patients with ... - Dove Medical Press - November 23rd, 2023
- BioLineRx Reports Third Quarter 2023 Financial Results and ... - PR Newswire - November 21st, 2023
- Why our Award Winners Beauty Box is the ultimate beauty gift (for ... - Yahoo Singapore News - November 21st, 2023
- SightCare Reviews - Is Official Website for Sight Care Legit to Try or ... - Vashon-Maury Island Beachcomber - November 21st, 2023
- Legend Biotech Reports Third Quarter 2023 Results and Recent ... - StreetInsider.com - November 21st, 2023
- Lorenzo's Oil: Can It Really Treat ALD? - Verywell Health - November 19th, 2023
- Doctor Says Living To 120 By End Of Decade Is Possible What's the Secret? - Benzinga - November 19th, 2023
- The week in pharma: action, reaction and insight week to ... - The Pharma Letter - November 19th, 2023
- Race Cannot Be Used To Predict Heart Disease, Scientists Say ... - Slashdot - November 19th, 2023
- SpaceX's Starship Reaches Outer Space Before Intentional ... - Slashdot - November 19th, 2023
- Mesenchymal Stem Cells Market is projected to reach USD 3,319 million by 2030 according to a new research r... - WhaTech Technology and Markets News - November 17th, 2023
- LMRUK: Protecting the next generation through cord blood - Charity Today News - November 17th, 2023
- Anti-aging molecule discovered that extends lifespan - Earth.com - November 17th, 2023
- Montana State researcher envisions living building materials that ... - Montana State University - November 17th, 2023
- OxyHelp Explores the Benefits of Hyperbaric Oxygen Therapy for ... - StreetInsider.com - November 15th, 2023
- Health benefits of bone marrow - Pakistan Observer - November 15th, 2023
- Evolving the standard of care: What is next for functional ... - NeuroNews International - November 15th, 2023
- Affimed Reports Third Quarter 2023 Financial Results and ... - BioSpace - November 15th, 2023
- Meet the World's First Whole-Eye Transplant Recipient - TIME - November 15th, 2023
- Calidi Biotherapeutics Reports Third Quarter 2023 Operating and ... - Business Wire - November 15th, 2023
- 10 Asia-Pacific biotech companies leading innovation in the region - Labiotech.eu - November 15th, 2023
- Fitspresso Reviews (November Update) Natural Ingredients That ... - Bainbridge Island Review - November 15th, 2023
- 2seventy bio Reports Third Quarter Financial Results and Recent ... - Business Wire - November 15th, 2023
- Japan To Create $6.6 Billion Fund To Develop Outer Space Industry ... - Slashdot - November 15th, 2023
- Be The Match, Healthcare Marketing Impact Awards 2023 - Ad Age - November 13th, 2023
- Medicare coverage saves lives. Enrolling shouldn't be this ... - Kevin MD - November 13th, 2023
- Future Ocean Foods: 36 Global Alt-Seafood Startups Form Association To Tackle Overfishing, Microplastics & More - Green Queen Media - November 13th, 2023
- Orchard Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 13th, 2023
- Celebrity doctor reveals Hollywoods hidden trend of stem cell antiaging therapies - Longevity.Technology - November 11th, 2023
- Amazon Expands Healthcare Push With One Medical Benefits For ... - Slashdot - November 11th, 2023
- Bene Meat Technologies becomes the first to receive EU approval ... - Pet Food Processing - November 11th, 2023
- FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma - Yahoo Finance - November 11th, 2023
- MaaT Pharma Provides Third Quarter 2023 Business Update and ... - Business Wire - November 11th, 2023
- IN8bio Reports Third Quarter 2023 Financial Results and Provides ... - GlobeNewswire - November 11th, 2023
- Fast Lean Pro Reviews - Overpriced or Optimal Ingredients That ... - Journal of the San Juan Islands - November 11th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - GlobeNewswire - November 11th, 2023
- Worlds first whole-eye and partial face transplant gives Arkansas man new hope - CNN - November 9th, 2023
- Glowing Fingertips And Green Eyes: First-of-Its-Kind Monkey ... - ScienceAlert - November 9th, 2023
- 10 Natural Body Scrubs That Exfoliate And Invigorate My Skin - PINKVILLA - November 9th, 2023
- CRISPR Therapeutics Provides Business Update and Reports Third ... - StreetInsider.com - November 9th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - StreetInsider.com - November 9th, 2023
- Sight Care Reviews - Overpriced or Worth the Hype? SightCare Pills ... - Journal of the San Juan Islands - November 9th, 2023
- 6 Amazing Health Benefits Of Giloy (Tinospora cordifolia) - WION - November 9th, 2023
- The Global Market for Bispecific Antibody Therapeutics Contract Manufacturing 2023-2030: Driven by Demand for Innovative Therapies and Promising... - November 7th, 2023
Recent Comments